Skip to content
ISSUE 10.29.26/24 CATEGORIES

CRISPR

9 articles tagged with #CRISPR

Scientist in lab coat and gloves transferring pink liquid using pipette.
Science

CRISPR 3.0: The Gene-Editing Revolution That's Quietly Changing Medicine

In December 2023, the FDA approved Casgevy — the first CRISPR-based therapy for a human disease. It works in a single treatment session: a patient's stem cells are removed, their DNA edited, and the corrected cells returned. The results in sickle cell disease trials were striking. But Casgevy uses first-generation CRISPR, which cuts DNA like scissors. A newer class of tools — base editing and prime editing — can rewrite individual letters of the genetic code without cutting the double helix at all, dramatically reducing the risk of unintended edits. Clinical trials of these next-generation systems began in 2024. The field is not waiting for the conversation to catch up.

Editorial Team·June 4, 2026·17 min
A male healthcare worker in protective gloves holding a small vial, focusing on medical research and safety.
Science

The Human Genome Revolution: From $3 Billion to $200 and What We Found

The Human Genome Project cost $3 billion, took 13 years, and involved 20 countries — to produce a sequence that was still 8 percent incomplete. A single lab can now sequence a human genome for under $200 in a single day. That price collapse, steeper than Moore's Law for a decade straight, has changed medicine, ancestry research, evolutionary biology, and our understanding of what 'the genome' actually is. The truly complete human genome, published in 2022, revealed nearly 200 million base pairs we never knew existed and overturned the idea that most DNA has no function.

Editorial Team·June 4, 2026·17 min